tiprankstipranks
Trending News
More News >
Mani, Inc. (JP:7730)
:7730
Japanese Market

Mani, Inc. (7730) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Mani, Inc.

(7730)

Rating:76Outperform
Price Target:
¥1,371.00
▲(14.44%Upside)
Mani, Inc. receives a solid score primarily due to its strong financial performance and short-term positive technical indicators. The company's stable balance sheet and efficient operations provide a reliable foundation, although free cash flow concerns and long-term technical weaknesses slightly dampen the score. Valuation metrics suggest the stock is fairly priced, with a decent dividend yield appealing to income investors.

Mani, Inc. (7730) vs. iShares MSCI Japan ETF (EWJ)

Mani, Inc. Business Overview & Revenue Model

Company DescriptionMani, Inc. (7730) is a Japanese company primarily engaged in the manufacture and sale of medical instruments, dental instruments, and surgical instruments. The company operates through various segments, including dental products, surgical products, and ophthalmic products. It provides a wide array of products such as dental reamers, root canal files, and other dental products, surgical sutures, needles, and other surgical instruments, as well as ophthalmic instruments and related products.
How the Company Makes MoneyMani, Inc. generates revenue through the sale of its medical, dental, and surgical instruments worldwide. The company earns a substantial portion of its income from the dental segment, which involves selling specialized tools and instruments to dental professionals and clinics. Additionally, its surgical products division contributes significantly to its earnings by providing hospitals and medical institutions with high-quality surgical sutures and needles. Mani, Inc. also benefits from its global distribution network and partnerships with healthcare providers, ensuring a consistent demand for its products across various international markets.

Mani, Inc. Financial Statement Overview

Summary
Mani, Inc. shows robust financial performance with strong revenue growth and profitability margins. The balance sheet is stable with minimal leverage, although free cash flow volatility due to high capital expenditures is a concern. Overall, the company is financially sound with a solid foundation for future growth.
Income Statement
90
Very Positive
Mani, Inc. demonstrates strong financial performance with a consistent increase in revenue from 2020 to 2024. The gross profit margin has remained robust, reflecting efficient cost management. Net profit margin has improved, indicating enhanced profitability. Notably, the EBIT and EBITDA margins have shown positive trends, underscoring operational efficiency.
Balance Sheet
85
Very Positive
The balance sheet of Mani, Inc. reflects financial stability with a low debt-to-equity ratio, indicating conservative leverage. The return on equity is strong, showcasing effective use of shareholders' equity to generate profits. A high equity ratio further illustrates the company's solid financial foundation.
Cash Flow
75
Positive
Mani, Inc. displays a mixed cash flow performance. While operating cash flow is healthy, free cash flow has shown volatility due to significant capital expenditures in recent years. The free cash flow to net income ratio is low, suggesting potential constraints in cash availability for strategic investments.
Breakdown
TTMSep 2024Sep 2023Sep 2022Sep 2021Sep 2020
Income StatementTotal Revenue
29.05B28.51B24.49B20.42B17.19B15.20B
Gross Profit
18.45B17.90B15.42B12.57B11.01B9.88B
EBIT
8.28B8.39B7.24B6.16B5.35B4.34B
EBITDA
10.47B10.70B9.94B9.17B7.55B6.26B
Net Income Common Stockholders
6.31B6.29B5.95B5.29B4.29B3.33B
Balance SheetCash, Cash Equivalents and Short-Term Investments
21.53B21.66B25.43B22.73B18.89B17.18B
Total Assets
57.33B57.18B54.98B50.11B42.69B39.29B
Total Debt
74.00M83.00M58.00M117.00M128.00M62.48M
Net Debt
-21.14B-21.56B-25.37B-22.61B-18.16B-17.11B
Total Liabilities
4.99B4.85B5.15B4.70B3.49B2.72B
Stockholders Equity
52.34B52.33B49.83B45.41B39.20B36.57B
Cash FlowFree Cash Flow
0.00129.00M4.31B4.62B2.52B248.97M
Operating Cash Flow
0.007.81B8.03B6.56B6.38B1.94B
Investing Cash Flow
0.00-6.64B-4.02B-2.17B-3.44B-38.33M
Financing Cash Flow
0.00-3.70B-3.25B-2.44B-2.23B-2.13B

Mani, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1198.00
Price Trends
50DMA
1181.82
Positive
100DMA
1286.36
Negative
200DMA
1538.36
Negative
Market Momentum
MACD
1.49
Negative
RSI
54.89
Neutral
STOCH
42.41
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7730, the sentiment is Positive. The current price of 1198 is below the 20-day moving average (MA) of 1203.55, above the 50-day MA of 1181.82, and below the 200-day MA of 1538.36, indicating a neutral trend. The MACD of 1.49 indicates Negative momentum. The RSI at 54.89 is Neutral, neither overbought nor oversold. The STOCH value of 42.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7730.

Mani, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$139.95B16.286.55%0.03%2.42%-13.12%
76
Outperform
¥118.03B19.55
2.67%11.54%-8.30%
73
Outperform
€162.32B28.384.78%2.74%20.53%-75.16%
69
Neutral
$634.25B60.237.09%0.67%17.38%-30.54%
61
Neutral
¥73.15B16.87
3.02%15.55%42.14%
61
Neutral
€79.26B14.086.62%2.69%4.56%24.11%
54
Neutral
$5.38B3.40-45.06%3.28%16.75%-0.02%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7730
Mani, Inc.
1,214.50
-627.69
-34.07%
JP:7979
Shofu Inc.
2,060.00
25.53
1.25%
JP:7716
Nakanishi
1,911.00
-353.74
-15.62%
JP:7780
Menicon Co
1,056.00
-177.70
-14.40%
JP:7747
Asahi Intecc Co
2,358.50
193.59
8.94%
JP:7817
Paramount Bed Holdings Co
2,608.00
-68.51
-2.56%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.